Monika Sekelja 👩🏻‍💻✨

PhD in Bioinformatics, interested in machine learning, AI, cancer vaccines, 3D DNA structure, space technology, spooky quantum physics stuff and techno gadgets

[Monika Sekelja 👩🏻‍💻✨ @SekeljaVision]

Please take time to see their talk!

[Tristan Harris @tristanharris]

Today we’re releasing “The A.I. Dilemma” – a new talk @aza and I gave on 3/9, a week before GPT4 launched.

*Pls share it widely.* It's critical for institutions to understand how the race between AI labs is accelerating the likelihood of catastrophe:
https://t.co/AMphLEUXc3

[Monika Sekelja 👩🏻‍💻✨ @SekeljaVision]

Join our In Silico and AI Department 🧬💻 In this role, you will lead computational modeling of protein and peptide structures in Nykode’s discovery projects!

https://t.co/y0nBPkLUbV
#proteinmodelling #AlphaFold #RoseTTAFold

[Dominic Esposito @domespo]

This is one area where improvement is needed in AlphaFold--it would be tremendously useful to predict structural changes caused by disease mutations and be able to correlate the effect of those changes on protein stability. Great commentary from @kyliejwalters

[Bio-IT World @bioitworld]

"Is Excel Holding Back Biopharmaceutical Research?" https://t.co/XPSJ7VOBLX

[The Telegraph @Telegraph]

🧪Now scientists have shown that if the xenobots are placed in a petri dish with embryonic frog stem cells, the bots sweep the cells up into little round piles which morph together into new organisms and also begin to move

[Alvin Foo @alvinfoo]

This is probably the best video describing how #COVID19 kills in the body. This video does a great job at visually showing the big picture that many are missing when they deny themselves the vaccine. 👍 https://t.co/61zC6N1scO

[Monika Sekelja 👩🏻‍💻✨ @SekeljaVision]

We, now Nykode Therapeutics, enter into groundbreaking license and collaboration agreement with Regeneron to develop innovative vaccines against cancer and infectious diseases.
https://t.co/BBetplB6Eb
Looking forward!
#vaccibody #nykode #cancertreatment #infectiousdiseases

[Monika Sekelja 👩🏻‍💻✨ @SekeljaVision]

Unique opportunity to join as Bioinformatician / Immunoinformatician, and work on the next generation vaccines against infectious diseases 🧬
https://t.co/HvKe1ATUsZ

#Vaccibody #Bioinformatician #Immunoinformatician

[Agnete B. Fredriksen @ABFredriksen]

We select our partners carefully! Enjoy the collaboration with the competent team at Adaptive Biotechnologies generating 3rd generations vaccines. Listen to the webcast at 4 pm today. https://t.co/0gYabSuZmW

[Monika Sekelja 👩🏻‍💻✨ @SekeljaVision]

Our Bioinformatics team is growing! 💻🧬 We are looking for a skilled Software Engineer for developing pipelines and software for treatments of cancer and infectious diseases.
https://t.co/03tZC17sX4

#Vaccibody #softwareengineer #bioinformatics

[Monika Sekelja 👩🏻‍💻✨ @SekeljaVision]

@AMathelier @jonnings Hey, I would love to join to drink and complain 😀 The school is closed today but no meetings are canceled ...

[Andreas Midbøe Hoff @AndreasMHoff]

There's a position out and a unique opportunity for a talented Bioinformatics Scientist to come join me and the skilled bioinformatics team @ Vaccibody to work on exciting projects related to shared cancer antigens. Read more about the role here:
https://t.co/7lWIgQ201S

[Monika Sekelja 👩🏻‍💻✨ @SekeljaVision]

Vaccibody webcast: Preclinical VB10.COV2 #COVID19 #coronavirus data summary and Infectious Disease Strategy: https://t.co/jEqDoIC4cd

[Monika Sekelja 👩🏻‍💻✨ @SekeljaVision]

Very promising results from our #covid19 DNA vaccine: a single dose of our vaccine targeting RBD to antigen-presenting cells induced rapid, strong and long-lasting neutralizing IgG, Th1 dominated CD4+ T cells and strong CD8+ T cell responses in mice: https://t.co/baMQyqHRnw

[Monika Sekelja 👩🏻‍💻✨ @SekeljaVision]

Bra innlegg, @Strumke! «Hvorfor er det lettere for meg å dele helsedata med Garmin enn med det norske helsevesenet, som jeg selv betaler skatt for og har egeninteresse av å støtte?»

[Inven2as @Inven2as]

Vår spin-off Vaccibody inngikk nylig norgeshistoriens største lisensavtale innen bioteknologi noensinne. Avtalen er med det svært anerkjente immunterapiselskapet Genentech, som er en del av Roche-gruppen. https://t.co/rFf5KQxcmO

[Monika Sekelja 👩🏻‍💻✨ @SekeljaVision]

This marks a beginning of an exciting new journey for #Vaccibody. We have entered worldwide agreement with Genentech 🥳 enabling us to accelerate our R&D programs https://t.co/kE7yJXYZsW

[Finansavisen @Finansavisen]

Vaccibody inngår en avtale verdt opptil 6,7 milliarder med Roche. Snart går kreftvaksineselskapet med Jan Haudemann-Andersen i spissen på børs. https://t.co/JmV7KQ1lcb

[Nordic Life Science @NLifeScience]

@ABFredriksen and her team at Vaccibody enters worldwide agreement with Genentech and accelerates R&D programs https://t.co/y6XiDlSiRD

[Genetic Analysis AS @GeneticAnalysis]

. Many COVID-19 patients report gastrointestinal symptoms.

. #sarscov2 RNA is detectable in the #stools of up to 50% of all #covid19 patients even after negative nasopharyngeal swab. #covid19testing, #diagnostics, GA-map COVID19 Fecal Test, #gut